Monopar Therapeutics Inc.

NASDAQ: MNPR · Real-Time Price · USD
37.95
-0.06 (-0.17%)
At close: Jun 06, 2025, 3:59 PM
37.11
-2.21%
After-hours: Jun 06, 2025, 04:04 PM EDT

Monopar Therapeutics Statistics

Share Statistics

Monopar Therapeutics has 6.12M shares outstanding. The number of shares has increased by -65.1% in one year.

6.12M
-65.1%
0.43%
6.8%
n/a
1,034
4.28%

Short Selling Information

The latest short interest is 38.03K, so 0.62% of the outstanding shares have been sold short.

38.03K
0.62%
1.97%
2

Valuation Ratios

The PE ratio is -0.05 and the forward PE ratio is -10.24. Monopar Therapeutics's PEG ratio is 0.

-0.05
-10.24
0
2.3
0.02
-130.2
0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Monopar Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 0.01, with a Debt / Equity ratio of 0.

0.01
0.01
0
n/a
n/a
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1,113,315,642.86
14
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 722.8% in the last 52 weeks. The beta is 1.01, so Monopar Therapeutics's price volatility has been higher than the market average.

1.01
722.8%
37.28
25.24
54.5
24,133

Income Statement

n/a
n/a
-16.16B
-15.59B
-15.59M
n/a
-411.23
Full Income Statement

Balance Sheet

The company has 45.82M in cash and 0 in debt, giving a net cash position of 45.82M.

45.82M
n/a
n/a
-75.79B
55.09B
53.58B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.4M and capital expenditures 0, giving a free cash flow of -6.4M.

-6.4M
n/a
-6.4M
-0.17
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

MNPR does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for MNPR is $50, which is 30.7% higher than the current price. The consensus rating is "Buy".

$50
30.7%
Buy
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Aug 13, 2024. It was a backward split with a ratio of 1:5.

Aug 13, 2024
backward
1:5

Scores

-0.94
1